Founded on the principles of patient driven results.

 

About us

Vessel Life Science's Strategic Pennsylvania MMJ Partners have been involved with medical cannabis since it was permissible in California in 1999, turning their focus to Colorado during the infancy stage of legalizing medical cannabis in 2009. With the benefit of more than 30 years’ combined experience, our partners have accumulated an extensive knowledge base across the spectrum of the cannabis industry, including engineered facilities, security, regulatory compliance, genetics, cultivation, good manufacturing practices (GMP), proprietary extraction methods, branding, retail operations (SOP), marketing and wholesale distribution.

Once cannabis was approved for medical use in Colorado, the team began working closely with patients who were finding relief from a variety of chronic conditions and disease, in order to optimize their results. The results were extremely encouraging, as indicated by patient testimonials. With success, the patient base grew, providing more data, and in turn, evidence for the effectiveness of particular therapies. These cannabinoid sequencing protocols serve as the basis for our partnership with Prana Bio Nutrient Medicinals and A.C.T. Now Programs.

Accredited with observational data from more than 15,000 patients to date,with Prana Bio Nutrients and A.C.T. Now Program garnered significant attention within the medical community, including Brent Reynolds Ph.D, William Yarosh Ph.D, and Dr. Barry Bialek who went on to join the United Cannabis Medical Advisory Board.

VesselLifeScience and its strategic Pennsylvania brand partnership with UCann,Prana and blueriver remains dedicated to advancing the use of cannabinoids in medicine with a focus on the refinement of genetics for medical grade strains of CBD-rich cannabis plants for the common wealth of pennsylvania's patient base. With the guidance from our exclusive partnerships, our company is also steadfast in its mission to bring best practices to the industry across all aspects of operation, planning, products, governance and patient care.

 

Exclusive Pennsylvania Partners

 

Collin Palmer
Partner, CEO

Collin Palmer is a life long resident of Pennsylvania, splitting his time between CA, NY and PA. Mr Palmer has over 16 years of experience spanning a diverse range of disciplines in production, marketing and advertising with a sharp eye for leadership. Mr. Palmer has been apart of building some of the worlds biggest brands and bringing products to market for clients such as, Viacom, Toyota, Chrysler , Philips, Canon, P&G and Unilever handling global accounts across several verticals from full global commercial campaigns all the way to beauty products, he has the ability to lead large teams with clarity across verticals. Mr. Palmers unique understanding of market trends and data are one of his keys principles to building a company focused on the patients needs rather then following trends. Additionally, Mr. Palmer has been featured in Rollingstone, I-D , ELLE and Esquire for his creative insight. 

 

Ernest Blackmon
Partner, Cultivar, United Cannabis

Earnest Blackmon is a horticulturalist and entrepreneur with over 20 years experience, including 5 years in the Commercial Cannabis Industry. Mr. Blackmon is currently an owner and the master grower at RiverRock Colorado and is responsible for the production, processing, workflow management, JIT inventory control, security, staffing, training and recruiting. Mr. Blackmon has developed a proprietary grow method based on an organic standard to aid in stable chemical synthesis to limit side reactions that diminish yield. Mr. Blackmon’s skill with operations, project management, quality control and cultivation insure that every United Cannabis production facility produces consistent high grade organic cannabis to meet the demands of our patients.

 

Tony Verzura
Partner, Terpene Extraction, BlueRiver Extracts

Tony Verzura oversees the A.C.T. Now Program, product manufacturing, quality assurance, product development, product training, staffing, and brand awareness. Mr. Verzura works hand in hand with the affiliated partners to help coordinate on boarding patient programs, standard operating procedures, and ensures company goals are being met worldwide. Mr. Verzura has been apart of over 30 Awards worldwide, including 5x 1st Place CBD Concentrate Awards, and has been featured on CNBC Money Talk as an honorary guest speaker. He has attended countless cannabis business conferences and events throughout the United States, Jamaica, Canada, Amsterdam, and Spain. He is a weekly panelist on the highly publicized educational YouTube show called Hash Church hosted by Bubbleman’s World.  His publications include The Washington Post, High Times, Culture Magazine, DOPE Magazine, Skunk Magazine, Sensi Seeds, and Frank 151.

 

Brent A. Reynolds
UCANN Chief Medical Advisor - Prana / Ucann

Brent A. Reynolds, Ph.D., attended the University of Calgary, where he received his M.Sc. and Ph.D. in 1989 and 1994, respectively. While working on his Ph.D. thesis Reynolds co-discovered the existence of stem cells in the adult mammalian brain, a finding that overcame a century old dogma that the mature brain did not have the capacity to repair itself. After graduating, Reynolds co‑founded the first neural stem cell company, NeuroSpheres, Ltd., where he was a director and vice president of research. Here he developed a strong patent portfolio in the neural stem cell field, developing and protecting protocols related to the application of stem cell technology in brain repair. Today, these patents and technology have been licensed to numerous biotechnology companies that are testing the efficacy in over half a dozen clinical trials for diseases such as spinal cord injury, stroke, ALS and pediatric disorders.  After a brief hiatus, where Reynolds studied and practiced Traditional Chinese Medicine, he returned to industry working with StemCell Technologies in Vancouver, Canada. In 2004, Reynolds returned to academic science as a professor at the Queensland Brain Institute at the University of Queensland in Australia where he continued refining the application of neural stem cells for repairing the damaged brain.  In 2008, Reynolds was recruited to the department of Neurosurgery at the University of Florida and has focused his efforts on studying aggressive pediatric and adult brain cancer and developing novel translational approaches to combat this lethal disease. Working with a multidisciplinary group of scientists, the team is taking the unique approach that cancer can be managed as a chronic disease by applying the principles that have been used in ecology to manage wildlife and pest populations. Based on the lessons learned over the past 80 years by ecologists, the team is focused on using multimodal low toxicity therapeutics to enforce a stable tumor population that exists below a threshold that has any harmful effects.  Dr. Reynolds has more than 60 publications, including papers in Science, Cell and Nature, with several manuscripts receiving over 1,000 citations. In addition, he is an inventor on 18 granted US patents.  Dr. Reynolds is currently a professor in the department of neurosurgery at UF; adjunct professor at the University of New South Wales, Sydney, Australia; an honorary professor at the Queensland Brain Institute, Australia; and program director for StepAhead, Australia. NIH, NHMRC and numerous foundations have funded his lab.

 

 

 

 

 

Our Brands


 
 
 
 
 
 
 

PRANA OVERVIEW

VesselLife Science is proud to offer Prana Bio Nutrient Medicinals exclusively in the common wealth of Pennsylvania. Prana offers a wide selections of raw and active cannabinoid supplements with multiple delivery methods that have accurately dosed medicine from 1mg to 100mg. These products and patient-driven programs are designed to help regulate the body’s endogenous endocannabinoid system, perhaps the most physiological system in maintaining human health. Thes products are used in conjunction with the extended services provided by the A.C.T. Now Program.

 

 

 

BLUERIVER OVERVIEW

Vessel Life Science and its strategic Pennsylvania partner United Cannabis provides Blue River Extracts global utility patents rights for the use of terpenes as a diluent in aromatherapy, vaporization, essential oils, edibles, aerosols, and for product branding purposes. Blue River provides full spectrum aromatherapy and essential oil profiles are derived naturally from specific plant based cultivars utilizing a proprietary chemical-free process.  Terpenes are produced by countless plant species, prevalent in fruits, vegetables, herbs, spices, and other botanicals. Terpenes are also common ingredients in the human diet and have generally been recognized as safe to consume by the US Food and Drug Administration..

 

 

 
 
 

Interested in working together? Here's our contact info.

 

Vessel Life Science